Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product ...
The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the treatment being hailed as a game-changer. | FDA is said to be making a U-turn on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results